Sunshine Biopharma (SBFM) EBT Margin (2015 - 2026)
Sunshine Biopharma (SBFM) reported EBT Margin of 15.38% for Q1 2026, down 167.0% on a YoY basis from 22.95% in Q1 2025, and up 23.87% quarter-over-quarter from 20.2% in Q4 2025.
Sunshine Biopharma (SBFM) EBT Margin (2015 - 2026) Analysis & Trends
Sunshine Biopharma has reported EBT Margin for 10 years, with the latest figure at 15.38% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin fell 167.0% year-over-year to 15.38%; the trailing twelve-month figure through Mar 2026 stood at 16.84% (down 2005.0% YoY), and the FY2025 full-year result was 16.4%, down 1962.0% from the prior year.
- EBT Margin for Q1 2026 stood at 15.38%, up from 20.2% in the prior quarter.
- The five-year high for EBT Margin was 43.81% in Q4 2024, with the low at 1097.09% in Q3 2022.
- Historically, EBT Margin has averaged 188.31% across 5 years, with a median of 15.38% in 2026.
- The largest YoY upside for EBT Margin was 1443245 bps in 2022 against a maximum downside of 137462 bps in 2022.
- Sunshine Biopharma's EBT Margin stood at 590.86% in 2022, then surged by 98 bps to 13.41% in 2023, then surged by 427 bps to 43.81% in 2024, then sank by 146 bps to 20.2% in 2025, then climbed by 24 bps to 15.38% in 2026.
- The last three EBT Margin figures came in at 15.38% (Q1 2026), 20.2% (Q4 2025), and 10.84% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 10.97% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 33.51% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 40.73% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 25.87% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 30.30% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.35% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -156.77% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -16.70% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 41.45% |
| 10 | Sunshine Biopharma | 10.94 Mn | 4.03 Mn | 2.18 Mn | -15.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.38% |
| Dec 31, 2025 | -20.20% |
| Sep 30, 2025 | -10.84% |
| Jun 30, 2025 | -21.04% |
| Mar 31, 2025 | -13.71% |
| Dec 31, 2024 | 43.81% |
| Sep 30, 2024 | -11.65% |
| Jun 30, 2024 | -9.01% |
| Mar 31, 2024 | -16.73% |
| Dec 31, 2023 | -13.41% |
| Sep 30, 2023 | -10.25% |
| Jun 30, 2023 | -14.65% |
| Mar 31, 2023 | -33.84% |
| Dec 31, 2022 | -590.86% |
| Sep 30, 2022 | -1,097.09% |
| Jun 30, 2022 | -358.51% |
| Mar 31, 2022 | -1,007.98% |
| Dec 31, 2021 | 783.75% |
| Sep 30, 2021 | -8,018.47% |
| Jun 30, 2021 | -5,445.12% |